ABSTRACT OBJECTIVES This study sought to investigate the effect of different body mass index (BMI) categories on clinical outcomes in female patients treated with percutaneous coronary intervention (PCI) and drug-eluting stents.
O besity represents a growing public health issue. It is estimated that more than two-thirds of U.S. adults are overweight with consequences on general and cardiovascular health and health care costs (1) . Body mass index (BMI) is an indicator of relative weight for height and is frequently used as a surrogate for the assessment of excess body fat and obesity.
A prospective study on more than 1.4 million white adults has shown that the risk of all-cause mortality in the general population has a "J" shape association with BMI with the lower mortality rate for a BMI of 25 kg/m 2 .
A progressive increase in mortality is observed for BMI values higher and lower than 25 kg/m 2 (2) .
Nevertheless, a growing body of evidence in the past decade has shown that among patients with chronic diseases, higher, instead of lower BMIs, are associated with better prognosis (3) (4) (5) (6) . This phenomenon is called "obesity paradox" or "reverse epidemiology." An inverse relation between BMI and cardiovascular outcomes has also been described after percutaneous coronary intervention (PCI), supporting the existence of the obesity paradox (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) ). Yet, evidence of this phenomenon in female patients undergoing contemporary PCI is very limited. In several reports on the obesity paradox in PCI patients, female patients accounted for less than 30% of the study population (19, 20) . In addition, it has been suggested that overweight and obese female patients might have a higher mortality rate than male counterparts after PCI. Although these data need to be interpreted with caution because of the small sample size and the observational nature of the study, they are certainly provocative and hypothesis generating (19) . Therefore, we sought to carefully evaluate the relation between BMI and risks of major cardiovascular events and mortality after PCI with drug-eluting stent (DES) in female patients using patient-level data from 26 randomized clinical trials. Tables 1 and 2 . Females with higher BMI were significantly younger but they were more likely to have hypertension, hyperlipidemia, diabetes mellitus, and family history of CAD. Rates of prior MI and PCI were unchanged among BMI groups, whereas history of coronary artery bypass graft was more common in patients with high BMI. At presentation, acute coronary syndromes were more frequent among lower BMIs, underweight, normoweight, and overweight, whereas stable angina was more prevalent in obese and severely obese patients. In addition, obese female patients had lower prevalence of multivessel
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Faggioni et al. Table 3 . At 3 years, unadjusted risk of MACE, all-cause mortality, and Values are n(%) or mean AESD.
Effects of Body Mass Index on Outcomes after PCI -2 0 1 7 : ---cardiac death were significantly higher in underweight patients compared with normal weight, whereas it was lower in overweight, obese, and severely obese subjects ( Figure 1) . After multivariable adjustment, the rate of MACE, MI, TLR, or definite/probable ST was not significantly different across the BMI groups ( Table 3 , Figure 2B ), whereas the risk of all-cause mortality and cardiac death remained over 2-fold higher in underweight patients ( Table 3) . The risk was the lowest in overweight patients and tended to increase in obese and severely obese patients describing an inverse "J-shaped" curve ( Figure 2A) . The observed relationship between mortality and BMI was unchanged at a sensitivity analysis performed using, as reference, a narrower BMI range for normoweight patients, between 20 and 24.9 (Online Figure 1) .
DISCUSSION
This is the largest study to date to evaluate the association between BMI and cardiovascular outcomes in a large female population with CAD treated with PCI and DES using pooled patient-level data from randomized trials. After adjusting for potential confounders, our results show that BMI affects all-cause mortality and cardiac death but has no clear relationship with other ischemic clinical outcomes.
Unsurprisingly, underweight female patients had a higher rate of all-cause mortality and cardiac death than normal weight patients. However, the risk was lower in overweight and increased slightly in severely obese patients suggesting a significant advantage of overweight patients in terms of all-cause mortality.
FIGURE 1 Kaplan-Meier Curves
Kaplan-Meier curves of 3-year mortality and MACE according to body mass index. MACE ¼ major adverse cardiovascular event(s). Tables 1 and 2 .
Faggioni et al. Adjusted risk of (A) all-cause mortality and cardiac death, and (B) MACE and myocardial infarction according to body mass index. Normoweight is used as reference. CI ¼ confidence interval; HR ¼ hazard ratio; MI ¼ myocardial infarction; other abbreviation as in Figure 1 .
Effects of Body Mass Index on Outcomes after PCI In addition, it should be noted that this analysis is based on randomized clinical trials data, which usually exclude high-risk patients. Finally, our dataset does not contain information on men. Therefore, the influence of BMI on outcomes in men cannot be ascertained and a direct comparison between female and male patients to investigate sex differences in the effect of BMI on outcomes is not attainable. Effects of Body Mass Index on Outcomes after PCI -2 0 1 7 : ---
CONCLUSIONS

